84 related articles for article (PubMed ID: 26159230)
1. Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
Santos MC; Silva PB; Rodini CO; Furukawa G; Marco Antonio DS; Zanotto-Filho A; Moreira JC; Okamoto OK
Stem Cells Dev; 2015 Nov; 24(22):2700-8. PubMed ID: 26159230
[TBL] [Abstract][Full Text] [Related]
2. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
3. miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.
Kaid C; Silva PB; Cortez BA; Rodini CO; Semedo-Kuriki P; Okamoto OK
Cancer Sci; 2015 Sep; 106(9):1188-95. PubMed ID: 26250335
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
5. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
6. Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.
Annabi B; Doumit J; Plouffe K; Laflamme C; Lord-Dufour S; Béliveau R
Mol Carcinog; 2010 Jul; 49(7):710-7. PubMed ID: 20564348
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.
Zhao Y; Xiao Z; Chen W; Yang J; Li T; Fan B
Mol Med Rep; 2015 Aug; 12(2):2313-22. PubMed ID: 25937029
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.
Rodini CO; Suzuki DE; Saba-Silva N; Cappellano A; de Souza JE; Cavalheiro S; Toledo SR; Okamoto OK
J Neurooncol; 2012 Jan; 106(1):71-9. PubMed ID: 21725800
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.
Närvä E; Rahkonen N; Emani MR; Lund R; Pursiheimo JP; Nästi J; Autio R; Rasool O; Denessiouk K; Lähdesmäki H; Rao A; Lahesmaa R
Stem Cells; 2012 Mar; 30(3):452-60. PubMed ID: 22162396
[TBL] [Abstract][Full Text] [Related]
11. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
13. L1TD1 is a marker for undifferentiated human embryonic stem cells.
Wong RC; Ibrahim A; Fong H; Thompson N; Lock LF; Donovan PJ
PLoS One; 2011 Apr; 6(4):e19355. PubMed ID: 21559406
[TBL] [Abstract][Full Text] [Related]
14. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of Cytoskeletal Protein Adducin 3 and CD133 in Neurospheres and a Temozolomide-resistant Subclone of Glioblastoma.
Poon MW; Zhuang JT; Wong ST; Sun S; Zhang XQ; Leung GK
Anticancer Res; 2015 Dec; 35(12):6487-95. PubMed ID: 26637861
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
[TBL] [Abstract][Full Text] [Related]
17. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
18. CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells.
Enguita-Germán M; Schiapparelli P; Rey JA; Castresana JS
Tumour Biol; 2010 Oct; 31(5):381-90. PubMed ID: 20480407
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71.
Matsuda Y; Ishiwata T; Yoshimura H; Hagio M; Arai T
Cancer Lett; 2015 Feb; 357(2):602-11. PubMed ID: 25527454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]